Bellevue Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-24,847
| Closed | -$1.62M | – | 221 |
|
|
2019
Q4 | $1.62M | Buy |
+24,847
| New | +$1.62M | 0.03% | 138 |
|
|
2019
Q1 | – | Sell |
-38,264
| Closed | -$3.24M | – | 143 |
|
|
2018
Q4 | $3.24M | Buy |
38,264
+20,198
| +112% | +$1.71M | 0.21% | 85 |
|
|
2018
Q3 | $3.09M | Sell |
18,066
-1,282
| -7% | -$220K | 0.2% | 93 |
|
|
2018
Q2 | $2.5M | Sell |
19,348
-7,342
| -28% | -$949K | 0.21% | 80 |
|
|
2018
Q1 | $2.75M | Sell |
26,690
-14,026
| -34% | -$1.45M | 0.27% | 65 |
|
|
2017
Q4 | $3.48M | Sell |
40,716
-37,350
| -48% | -$3.19M | 0.36% | 60 |
|
|
2017
Q3 | $6.63M | Sell |
78,066
-23,564
| -23% | -$2M | 0.69% | 47 |
|
|
2017
Q2 | $7.7M | Sell |
101,630
-88,390
| -47% | -$6.69M | 0.91% | 46 |
|
|
2017
Q1 | $12.5M | Sell |
190,020
-9,602
| -5% | -$634K | 1.67% | 19 |
|
|
2016
Q4 | $12.7M | Buy |
199,622
+28,293
| +17% | +$1.79M | 2.59% | 9 |
|
|
2016
Q3 | $10.9M | Buy |
171,329
+57,468
| +50% | +$3.66M | 1.97% | 12 |
|
|
2016
Q2 | $8.47M | Sell |
113,861
-17,312
| -13% | -$1.29M | 1.59% | 18 |
|
|
2016
Q1 | $8.76M | Buy |
+131,173
| New | +$8.76M | 1.59% | 18 |
|